Treatment for overactive bladder

Der Urologe, 07/26/2011

This subgroup analysis of the CAP Study confirms the good efficacy and tolerability of solifenacin in male overactive bladder (OAB) in daily practice over a treatment period of 1 year.

Print Article Summary Cat 2 CME Report